kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the VTGN dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for VTGN.

VTGN

Vistagen Therapeutics, Inc.
Healthcare · Biotechnology
$71.21 sample
-1.07 (-1.48%) 1D
☆ Watch
Market cap
$279.3B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-21
Alerts
8
Price$71.21 +10.83% 3M daily closessample
72.7862.25
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 21SECForm 144 filed
  • Oct 12SEC8-K filed: material event
  • Oct 05SEC8-K filed: material event
  • Sep 24SEC8-K filed: material event
  • Sep 17INSInsider sell: Director
  • Sep 08INSInsider buy: Chief Financial Officer
  • Aug 28INSInsider sell: Chief Executive Officer
  • Aug 24SEC10-Q filed
Sign up to see the real VTGN record →

Company facts

SEC EDGAR registration
Name
Vistagen Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-44sample, -100 to +100
Reporting currency
USD

Who is positioning in VTGN

sample
Insiders
33 insider transactions over 90 days, net selling, $171.0M
Congress
No member trades over 90 days
Institutions · 13F
39 funds hold $3.0B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$7.3B +20.3% y/y
Q4 2024Q3 2026
Inventory$4.2B +9.5% y/y
Q4 2024Q3 2026
Accounts receivable$3.2B +13.0% y/y
Q4 2024Q3 2026
Total debt$8.6B +9.7% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$72.8B +3.5% 3M
Sample peer B
$178.1B -6.7% 3M
Sample peer C
$208.5B +11.9% 3M
Sample peer D
$89.4B -11.8% 3M
Sample peer E
$70.0B -12.2% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not VTGN's real figure. Nothing here is investment advice.